BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+38.1%
5Y CAGR+37.7%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+38.1%/yr
vs +39.3%/yr prior
5Y CAGR
+37.7%/yr
Consistent
Acceleration
-1.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$19.85M+15.1%
2024$17.25M-4.4%
2023$18.04M+139.2%
2022$7.54M+565.7%
2021$1.13M-71.8%
2020$4.01M-55.0%
2019$8.91M+344.9%
2018$2.00M+5038.5%
2017$39000.00-